2019 Speakers

  • Petra Booij

    Investigator GlaxoSmithKline, UK

    Petra obtained a PhD in analytical chemistry from the VU University in Amsterdam, The Netherlands. She is currently working in GSKs E&L team based in Stevenage (UK). Her work focusses on trace level analysis, identification and confirmation of E&L using mass spectrometry, and risk assessments of E&L within biopharma and cell and gene therapy. She is a member of the ELSIE leachable team and involved in harmonising approaches for leachable testing.

  • Thomas Egert

    Analytical Development Boehringer Ingelheim Pharmaceuticals

    Thomas Egert is a research scientist at Boehringer Ingelheim, Germany. Dedicated to analytical chemistry for 20+ years, his current role includes responsibility for materials selection and E&L qualification as well as analytical troubleshooting during packaging development.

    Thomas is an active member of the Extractables and Leachables Safety Information Exchange Consortium (ELSIE) and the PQRI Parenteral and Ophthalmic Drug Product (PODP) – E&L Working Group. While contributing to several industry seminars in the field of pharmaceutical packaging, his special interest is devoted to predictive physico-chemical models for mass transfer from primary contact materials into pharmaceuticals.

    Prior to joining Boehringer Ingelheim, Thomas held various positions in the field of organic trace analysis at an analytical service provider. Thomas holds a diploma in chemical engineering and a master’s degree in bio- and pharmaceutical analysis.

  • Dr. Nina Macho

    Scientist Pharmacology and Toxicology Octapharma, Austria

    Nina Macho graduated in nutritional sciences at the University of Vienna, and in toxicology at
    the Medical University of Vienna. After investigating dietary factors which protect against
    DNA damage at the Cancer Research Institute of Vienna, she worked in the field of
    ecotoxicology at the Austrian Institute of Technology. In 2013 she joined the Department of
    Pharmacology and Toxicology at Octapharma. In her current position, Nina is responsible for
    toxicological risk assessment of impurities in biopharmaceutical products.

  • Asger Wisti Nørgaard

    Senior Research Scientist Novo Nordisk, Denmark

    Biography to follow 

  • Patricia Parris

    Project Toxicologist AstraZeneca, UK

    Trish is a Project Toxicologist in Drug Safety & Metabolism within AstraZeneca and has a background in Genetic Toxicology. She joined AstraZeneca in 2015 and in addition to managing the non-clinical safety strategy for respiratory and inflammatory disease pharmaceuticals she has a global role providing guidance on all aspects of drug impurity issues. In recent years, Trish has worked with the ICH M7 sub-group to develop the Addendum table co-authoring the hydrogen peroxide monograph; and the vinyl acetate monograph in the subsequent publication Bercu et al., (2018). Trish is also the co-chair of the Extractables and Leachables Safety Information Exchange (ELSIE) PDE Sub-team.



  • Tom Van Wick

    Principal Scientist Abbott

    All-round scientist with recognized expertise in HPLC and capillary electrophoresis hyphenated with mass spectrometry in the field of impurity profiling and structure elucidation. 
    Experience in management functions as well as project responsible scientist representing analytical development in working in multi-disciplinary project teams. 
    Strong affinity with efficiency improvements. Recognized for drive, enthusiasm, innovation, high quality performance and a pragmatic approach.

    Area: Chemical and pharmaceutical development (R&D, manufacturing)
    Key interests: Mass spectrometry, HPLC method development, Electrophoresis, Genotox impurities, Heavy metal analysis, Extractables and leachables